SFX by Ex Libris Inc.

Title:	Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach
Source:	Acs Medicinal Chemistry Letters [1948-5875] Chen, Chao yr:2016

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mobitz, H. "Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach." ACS medicinal chemistry letters. 8.3: 338-343.
description	2.	Luo, M. "Identification of phenoxyacetamide derivatives as novel DOT1L inhibitors via docking screening and molecular dynamics simulation." Journal of molecular graphics & modelling 68 (2016): 128-139.
description	3.	Mahato, D. "A systems biology approach for elucidating the interaction of curcumin with Fanconi anemia FANC G protein and the key disease targets of leukemia." Journal of receptor and signal transduction research 37.3 (2017): 276-282.
description	4.	Scheufler, C. "Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket." ACS medicinal chemistry letters 7.8 (2016): 730-734.
description	5.	"EthR for use as ethionamide boosters." Organic & biomolecular chemistry. 14.7: 2318-2326.
description	6.	Spurr, S. "New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms." Bioorganic and medicinal chemistry letters 26.18 (2016): 4518-4522.
description	7.	Pollock, Roy A. "Potent inhibition of DOT1L as treatment of MLL-fusion leukemia." Blood 122.6 (2013): 1017-1025.
description	8.	Abbasi, M. "Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening." Journal of molecular graphics & modelling 61 (2015): 186-195.
description	9.	El-Sayed, S. "Biochemical stability and molecular dynamic characterization of Aspergillus fumigatus cystathionine γ-lyase in response to various reaction effectors." Enzyme and microbial technology 81 (2015): 31-46.
description	10.	Vuorinen, A. "Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling." Methods 71.C (2015): 113-134.
description	11.	Kudithipudi, S. "The SUV39H1 Protein Lysine Methyltransferase Methylates Chromatin Proteins Involved in Heterochromatin Formation and VDJ Recombination." ACS chemical biology 12.4 (2017): 958-968.
description	12.	Daigle, Scott R. "Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor." Cancer cell 20.1 (2011): 53-65.
description	13.	ChemMedChem. 8.9: 1451-1456.
description	14.	Schapira, M. "Methyltransferase inhibitors for modulation of the epigenome and beyond." Current opinion in chemical biology 33 (2016): 81-87.
description	15.	Lu, R. "Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development." Cancer cell 30.1 (2016): 92-107.
description	16.	Katsuyama, S. "Identification of a novel compound that inhibits osteoclastogenesis by suppressing nucleoside transporters." FEBS letters 590.8 (2016): 1152-1162.
description	17.	Anglin, Justin L. "A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1L." Journal of medicinal chemistry 56.22 (2013): 8972-8983.
description	18.	Yu, W. "Bromo-deaza-SAH: a potent and selective DOT1L inhibitor." Bioorganic & medicinal chemistry 21.7 (2013): 1787-94.
description	19.	Regan, C. "A facile synthesis of 5-halopyrimidine-4-carboxylic acid esters via a Minisci reaction." Synlett 23.3 (2012): 443-447.
description	20.	Yao, Y. "Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis and Crystallographic Studies." Journal of the American Chemical Society 133.42 (2011): 16746-16749.